| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Adnan Mushtaq | |
| Mohamed El-Azizi | |||
| Nancy Khardori | |||
| P2860 | cites work | Historical trends related to bioterrorism: An empirical analysis | Q24647658 |
| Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. | Q27471311 | ||
| West Nile Encephalitis in Israel, 1999: The New York Connection | Q27487805 | ||
| Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia | Q27489407 | ||
| Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States | Q27860919 | ||
| Biological warfare. A historical perspective | Q28245363 | ||
| Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin | Q28245552 | ||
| Tick-borne virus diseases of human interest in Europe | Q28298829 | ||
| Probable person-to-person transmission of avian influenza A (H5N1) | Q28304014 | ||
| Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses | Q28353147 | ||
| A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 | ||
| Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China | Q29618055 | ||
| Oseltamivir resistance during treatment of influenza A (H5N1) infection | Q29618722 | ||
| Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis | Q30312048 | ||
| Avian influenza and human health. | Q30330442 | ||
| Nipah virus: a recently emergent deadly paramyxovirus | Q30596767 | ||
| Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial | Q31931976 | ||
| Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group | Q33492333 | ||
| Outbreak of Nipah-virus infection among abattoir workers in Singapore | Q33751532 | ||
| Biological warfare and bioterrorism | Q33809068 | ||
| Update: outbreak of Nipah virus--Malaysia and Singapore, 1999. | Q33864666 | ||
| The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience | Q33893693 | ||
| Neurologic manifestations and outcome of West Nile virus infection | Q33967282 | ||
| Detection of West Nile virus in blood donations--United States, 2003. | Q33967746 | ||
| Influenza pandemics and avian flu. | Q34131770 | ||
| Risks and prevention of nosocomial transmission of rare zoonotic diseases | Q34136684 | ||
| Transmission of West Nile virus from an organ donor to four transplant recipients | Q34201110 | ||
| Laboratory diagnosis of Nipah and Hendra virus infections | Q34239763 | ||
| Avian influenza A (H5N1) in 10 patients in Vietnam | Q34301283 | ||
| Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: hantavirus). | Q34444217 | ||
| Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. | Q34529099 | ||
| Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus | Q34542855 | ||
| Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. | Q34624531 | ||
| Threats in bioterrorism. II: CDC category B and C agents | Q34743497 | ||
| Human monkeypox -- Kasai Oriental, Democratic Republic of Congo, February 1996-October 1997. | Q34743925 | ||
| Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up | Q35082338 | ||
| Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. | Q35536588 | ||
| Human disease from influenza A (H5N1), Thailand, 2004. | Q35873321 | ||
| Treatment and vaccines for severe acute respiratory syndrome | Q36070672 | ||
| Reemergence of monkeypox: prevalence, diagnostics, and countermeasures | Q36313212 | ||
| Bunyaviridae genome structure and gene expression | Q37437131 | ||
| A cluster of cases of severe acute respiratory syndrome in Hong Kong. | Q37869740 | ||
| Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa | Q38879568 | ||
| The transmission potential of monkeypox virus in human populations | Q39004777 | ||
| Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus | Q39338373 | ||
| Tick-borne encephalitis (FSME)--how great is the danger really? | Q40535393 | ||
| Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
| High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome | Q40565464 | ||
| Outbreak of West Nile-like viral encephalitis--New York, 1999. | Q40630161 | ||
| Update: West Nile-like viral encephalitis--New York, 1999. | Q40630495 | ||
| Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia | Q40631596 | ||
| Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections | Q40666918 | ||
| Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness | Q40710165 | ||
| Hemorrhagic fever with renal syndrome: mode of transmission to humans | Q40795176 | ||
| A common-source outbreak of Crimean-Congo haemorrhagic fever on a dairy farm | Q40814531 | ||
| The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses | Q40837861 | ||
| Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976. | Q40859167 | ||
| Bird flu and pandemic flu. | Q42618422 | ||
| Genetic analysis of West Nile New York 1999 encephalitis virus | Q42996823 | ||
| The Nipah virus outbreak--a reminder | Q43209304 | ||
| Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. | Q43209654 | ||
| Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States | Q43213015 | ||
| Meningoencephalitis caused by a novel paramyxovirus: an advanced MRI case report in an emerging disease | Q43214551 | ||
| Emerging diseases. Malaysian researchers trace Nipah virus outbreak to bats | Q43214959 | ||
| Risk factors for Nipah virus transmission, Port Dickson, Negeri Sembilan, Malaysia: results from a hospital-based case-control study | Q44018902 | ||
| Biotechnology: impact on biological warfare and biodefense | Q44811695 | ||
| Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha | Q45249786 | ||
| Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida | Q45787835 | ||
| Multistate outbreak of monkeypox--Illinois, Indiana, and Wisconsin, 2003. | Q46834704 | ||
| Oseltamivir resistance--disabling our influenza defenses | Q46863506 | ||
| Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients | Q47815818 | ||
| Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. | Q47818456 | ||
| Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units | Q47820521 | ||
| Treatment of acute Nipah encephalitis with ribavirin. | Q50585728 | ||
| Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. | Q51636852 | ||
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. | Q51660929 | ||
| Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). | Q51674509 | ||
| Tick‐Borne Encephalitis | Q56609476 | ||
| Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003 | Q57104836 | ||
| Severe Acute Respiratory Syndrome | Q59187114 | ||
| Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus) | Q60032093 | ||
| Tick-borne encephalitis | Q73074722 | ||
| Hantavirus pulmonary syndrome--United States: updated recommendations for risk reduction. Centers for Disease Control and Prevention | Q74653539 | ||
| Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism | Q77109857 | ||
| [Tick-borne encephalitis: clinical, pathological aspects and sequelae] | Q79828242 | ||
| P433 | issue | 2 | |
| P921 | main subject | bioterrorism | Q854975 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 423-41, x | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Category C potential bioterrorism agents and emerging pathogens | |
| P478 | volume | 20 |
| Q35658146 | Hendra and nipah infection: pathology, models and potential therapies | cites work | P2860 |
Search more.